| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/25/2013 | US8470854 Lactam-containing compounds and derivatives thereof as factor XA inhibitors |
| 06/25/2013 | US8470850 Inhibitors of VEGF receptor and HGF receptor signalling |
| 06/25/2013 | US8470808 Oxidant scavengers for treatment of type I diabetes or type II diabetes |
| 06/25/2013 | US8470784 Methods and compositions for preventing or treating ophthalmic conditions |
| 06/25/2013 | US8470311 Therapeutic agent for anaerobic diseases |
| 06/25/2013 | US8470301 Particulate materials |
| 06/25/2013 | CA2725425C Homocysteine synthase inhibitor |
| 06/25/2013 | CA2654210C Association of a sinus current inhibitor if and a beta blocker |
| 06/25/2013 | CA2647512C Substance exhibiting neuromodulator activity |
| 06/25/2013 | CA2633074C Elongase genes and uses thereof |
| 06/25/2013 | CA2598988C Cyclohepta[b]pyridine-3-carbonylguanidine derivative and pharmaceutical product containing the same as nhe inhibitors |
| 06/25/2013 | CA2595290C Diazabenzo[de]anthracen-3-one compounds and methods for inhibiting parp |
| 06/25/2013 | CA2591912C Pyrimidinylisoxazole derivatives |
| 06/25/2013 | CA2588963C 1-substituted-3-.beta.-d-glucopyranosylated nitrogenous hetero-cyclic compounds and medicines containing the same |
| 06/25/2013 | CA2551611C Thiazole derivatives for treating or preventing parkinson's disease |
| 06/25/2013 | CA2482464C Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease |
| 06/25/2013 | CA2480217C G-type peptides to ameliorate atherosclerosis |
| 06/25/2013 | CA2458798C Method for reducing hypertension and heart failure |
| 06/25/2013 | CA2380940C Substances and agents for positively influencing collagen |
| 06/20/2013 | WO2013090833A1 Angiotensins for treatment of fibrosis |
| 06/20/2013 | WO2013090750A1 Uses of 4'-desferrithiocin analogs |
| 06/20/2013 | WO2013090452A1 Sustained release particle formulations |
| 06/20/2013 | WO2013090210A1 Metalloenzyme inhibitor compounds |
| 06/20/2013 | WO2013090196A1 Combinations of azilsartan and chlorthalidone for treating hypertension black patients |
| 06/20/2013 | WO2013089164A1 Thromboembolism preventive/therapeutic agent for thromboembolism patients having severe renal dysfunction |
| 06/20/2013 | WO2013088382A1 Therapy for subarachnoid hemorrhage and ischemia |
| 06/20/2013 | WO2013087643A1 1,3,5 -triazine-2-amine derivatives, preparation thereof and diagnostic and therapeutic use thereof |
| 06/20/2013 | WO2013087234A1 Nanoparticles and uses thereof |
| 06/20/2013 | WO2013063383A3 Vectors encoding rod-derived cone viability factor |
| 06/20/2013 | WO2013062332A3 Vascular anti-aging composition including syringaresinol |
| 06/20/2013 | WO2013062316A3 Composition containing modafinil or the derivatives thereof for treating vascular diseases or kca3.1-channel-mediated diseases |
| 06/20/2013 | WO2013058632A3 Composition containing ohioensins f as a polytrichastrum alpinum-derived novel compound for preventing or treating arteriosclerosis |
| 06/20/2013 | WO2013058630A3 Composition containing stereocalpin a as a novel compound for preventing or treating arteriosclerosis |
| 06/20/2013 | WO2013045380A3 Pharmaceutically acceptable mglur5 positive allosteric modulators and their methods of identification |
| 06/20/2013 | WO2013007725A3 Aliskiren hemifumarate, crystal form and amorphous solid |
| 06/20/2013 | US20130158502 Method of inhibiting angiogenesis or invasion or formation of metastases |
| 06/20/2013 | US20130158234 Specific binding agents of human angiopoietin-2 |
| 06/20/2013 | US20130158084 Pharmaceutical Composition Comprising Losartin For Treating or Preventing Statin BasedGrug-Induced Muscle Toxicity |
| 06/20/2013 | US20130157311 Methods of Determination of Activation or inactivation of Atrial Natriuretic Peptide (ANP) and Brain Natriuretic Peptide (BNP) Hormonal Systems |
| 06/20/2013 | US20130156696 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 06/19/2013 | EP2604697A1 Triprenyl phenol compounds, process for their production and use as thrombolysis enhancer |
| 06/19/2013 | EP2604686A1 Highly functionalized stem cell/progenitor cell by ape1 gene transfection |
| 06/19/2013 | EP2604606A1 Inhibitor of casein kinase 1 and casein kinase 1 |
| 06/19/2013 | EP2604272A1 Effective fraction from the fruiting bodies of ganoderma lucidum, extraction method, use and preparation thereof |
| 06/19/2013 | EP2603588A1 Injectable pharmaceutical composition for preventing, stabilising and/or inhibiting pathological neovascularization-related conditions |
| 06/19/2013 | EP2603503A1 Dabigatran etexilate bismesylate salt, solid state forms and process for preparation thereof |
| 06/19/2013 | EP2603502A1 4 - aminoquinazolin- 2 - yl - 1 - pyrrazole - 4 - carboxylic acid compounds as prolyl hydroxylase inhibitors |
| 06/19/2013 | EP2603199A1 Compositions and methods for treating cardiovascular disease |
| 06/19/2013 | CN103168041A 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof |
| 06/19/2013 | CN103168033A Quinazoline compounds as sodium channel blockers |
| 06/19/2013 | CN103168028A Cyclic amide derivative |
| 06/19/2013 | CN103167870A Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues |
| 06/19/2013 | CN103160557A Purpose of ribosomal protein S5 in catalyzing of protein molecules for generatation of dephosphorylation reaction |
| 06/19/2013 | CN103159860A Recombinant tissue-type plasminogen activator, and preparation method and use thereof |
| 06/19/2013 | CN103159847A Natriuretic peptide, as well as gene and use thereof |
| 06/19/2013 | CN103159788A Condensed imidazole formamide serving as transient receptor potential vanillin 3 (TRPV3) modifier |
| 06/19/2013 | CN103159742A 5-Chloropyrimidine compound and application of 5-Chloropyrimidine compound serving as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor |
| 06/19/2013 | CN103159726A Chromene ketone derivative used as transient receptor potential vanillin3 (TRPV3) antagonist |
| 06/19/2013 | CN103159667A 6-guanidyl-2H-isoindole compound as well as preparation method and application thereof |
| 06/19/2013 | CN103158941A Method for improving light stability of fasudil or its salt injection liquid |
| 06/19/2013 | CN103157083A Medicament for treating premature beat |
| 06/19/2013 | CN103157078A Drug for curing pulmonary heart disease |
| 06/19/2013 | CN103157068A Traditional Chinese medicine composition powder for treating coronary occlusion and preparation method thereof |
| 06/19/2013 | CN103157060A Pure traditional Chinese medicine composition having effects of dredging meridian and activating collaterals, as well as promoting qi circulation and eliminating blood stasis, and preparation method for same |
| 06/19/2013 | CN103157014A Miao medicine for treating tumors |
| 06/19/2013 | CN103157003A Preparation method of pumpkin-fermented medicated wine as well as product and use of pumpkin-fermented medicated wine |
| 06/19/2013 | CN103157001A Medicament for treating rheumatic heart disease |
| 06/19/2013 | CN103157000A Traditional Chinese medicine for treating sinus syndrome |
| 06/19/2013 | CN103156996A Traditional Chinese medicine preparation for treating dilated myocarditis and preparation method thereof |
| 06/19/2013 | CN103156987A Miao medicine for reducing blood pressure |
| 06/19/2013 | CN103156982A Medicine for treating rheumatic heart disease |
| 06/19/2013 | CN103156977A Traditional Chinese medicine for treating hypertension with syndrome of yin deficiency and yang excess |
| 06/19/2013 | CN103156975A Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, and preparation method thereof |
| 06/19/2013 | CN103156939A External compound preparation for treating hemorrhoids |
| 06/19/2013 | CN103156934A Traditional Chinese medicine for treating apoplexy sequela |
| 06/19/2013 | CN103156929A 脑瘫康丸 Cerebral palsy Pill |
| 06/19/2013 | CN103156916A Pharmaceutical composition for treating heart disease |
| 06/19/2013 | CN103156904A Pure traditional Chinese medicine composition for treating hypertension and preparation method for same |
| 06/19/2013 | CN103156901A Medicament suitable for early painful shock |
| 06/19/2013 | CN103156893A Novel application for angelica polymorpha maxim and extract thereof |
| 06/19/2013 | CN103156882A Injection for one-needle removal of hemorrhoids and mole and wart removal paste and preparation method of injection and paste |
| 06/19/2013 | CN103156875A Application of icariin in preparation of medicine for promoting angiogenesis |
| 06/19/2013 | CN103156870A Pharmaceutical composition for treating cardiovascular disease and preparation method thereof |
| 06/19/2013 | CN103156866A Injectable drug for treating varicosity |
| 06/19/2013 | CN103156865A Application of L-arabinose in preparing medicines or health-care products |
| 06/19/2013 | CN103156847A Novel application of pitavastatin calcium |
| 06/19/2013 | CN103156842A Novel application of Arctigenin in preparation of anti-arrhythmia medicine |
| 06/19/2013 | CN103156829A Application of polyhydroxy bromo-benzophenone compound and derivatives thereof in treatment and prevention of atherosclerosis |
| 06/19/2013 | CN103156807A Buflomedilhydroc hloride injection and preparation method thereof |
| 06/19/2013 | CN103156129A Black medical soybean food obtained by immersing black soybean through life-cultivating and health-care vinegar medical tea to carry out biological fermentation |
| 06/19/2013 | CN102743350B Methionine-vitamin B1 composition injection and preparation method thereof |
| 06/19/2013 | CN102626162B Nutrition food heart-nourishing tea granule for nourishing hearts |
| 06/19/2013 | CN102488210B Genistein hydrogel compound and its preparation method |
| 06/19/2013 | CN102429886B Indapamide osmotic pump preparation and preparation method thereof |
| 06/19/2013 | CN102391250B Dabigatran compound and preparation method and medicinal composition thereof |
| 06/19/2013 | CN102367227B Stable Levocarnitine compound and pharmaceutical composition thereof |
| 06/19/2013 | CN102357231B Detection method of compound fructus embeliae haemorrhoid suppository |
| 06/19/2013 | CN102335352B Traditional Chinese medicine composition for treating ischemic cerebral apoplexy |
| 06/19/2013 | CN102276585B Preparation method for and medicinal usage of 4-substituted-phenyl-aryl-carboxylate derivatives |
| 06/19/2013 | CN102250342B PEG/mPEG (Polyethylene Glycol) multi-carboxyl chemical modifying agent connected with citric acid, preparation method and application thereof in modification of toluylene compound |